From 9b9ea83f691913f6e844fe0b64fb6dfaeef001e5 Mon Sep 17 00:00:00 2001 From: borja Date: Wed, 30 Oct 2024 14:46:18 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/InCORNTD 2025___Application.md | 3 ++- 1 file changed, 2 insertions(+), 1 deletion(-) diff --git a/pages/InCORNTD 2025___Application.md b/pages/InCORNTD 2025___Application.md index 24bf0056..bc61445b 100644 --- a/pages/InCORNTD 2025___Application.md +++ b/pages/InCORNTD 2025___Application.md @@ -2,5 +2,6 @@ - **Título**: Fixed dose albenzadole/ivermectin coformulation, an innovative tool to help countries achieve their NTD control goals in a post-donation era - **Description**: The fixed-dose coformulation of albendazole and ivermectin is the result of 10+ years of innovations carried out by African and European organizations working through public-private partnerships. This orodispersible, mango-flavoured tablet has already demonstrated safety and efficacy against soil-transmitted helminths in a pivotal trial, although its potential uses go beyond these parasites. - The fixed-dose combination of albendazole and ivermectin provides a novel approach to + The fixed-dose combination of albendazole and ivermectin provides a novel approach to mass drug administration campaigns that simplifies logistics while providing better efficacy against more species of helminths. + While the frequently used albendazole 400mg monotherapy - \ No newline at end of file